Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001641172-25-017863
Filing Date
2025-07-03
Accepted
2025-07-03 17:23:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 form424b5.htm 424B5 612773
2 GRAPHIC form424b5_001.jpg GRAPHIC 7992
  Complete submission text file 0001641172-25-017863.txt   625068
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE #210 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE #210 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Filer) CIK: 0001860871 (see all company filings)

EIN.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-288218 | Film No.: 251106402
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)